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Abstract
Background: A crucial event in the development of the vertebrate neuromuscular junction (NMJ)
is the postsynaptic enrichment of muscle acetylcholine (ACh) receptors (AChRs). This process
involves two distinct steps: the local clustering of AChRs at synapses, which depends on the
activation of the muscle-specific receptor tyrosine kinase MuSK by neural agrin, and the global
dispersal of aneural or "pre-patterned" AChR aggregates, which is triggered by ACh or by
synaptogenic stimuli. We and others have previously shown that tyrosine phosphatases, such as the
SH2 domain-containing phosphatase Shp2, regulate AChR cluster formation in muscle cells, and
that tyrosine phosphatases also mediate the dispersal of pre-patterned AChR clusters by
synaptogenic stimuli, although the specific phosphatases involved in this latter step remain
unknown.
Results: Using an assay system that allows AChR cluster assembly and disassembly to be studied
separately and quantitatively, we describe a previously unrecognized role of the tyrosine
phosphatase Shp2 in AChR cluster disassembly. Shp2 was robustly expressed in embryonic
Xenopus muscle in vivo and in cultured myotomal muscle cells, and treatment of the muscle
cultures with an inhibitor of Shp2 (NSC-87877) blocked the dispersal of pre-patterned AChR
clusters by synaptogenic stimuli. In contrast, over-expression in muscle cells of either wild-type or
constitutively active Shp2 accelerated cluster dispersal. Significantly, forced expression in muscle of
the Shp2-activator SIRPα1 (signal regulatory protein α1) also enhanced the disassembly of AChR
clusters, whereas the expression of a truncated SIRPα1 mutant that suppresses Shp2 signaling
inhibited cluster disassembly.
Conclusion: Our results suggest that Shp2 activation by synaptogenic stimuli, through signaling
intermediates such as SIRPα1, promotes the dispersal of pre-patterned AChR clusters to facilitate
the selective accumulation of AChRs at developing NMJs.
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Background
Synapses facilitate efficient neuronal communication by
bringing close together the organelles and molecules
involved in the release and detection of neurotransmit-
ters. Thus, to understand how synapses function, it is nec-
essary to elucidate the signaling pathways that regulate the
development of cellular specializations unique to syn-
apses. For this purpose, one particular synaptic specializa-
tion – found at the vertebrate neuromuscular junction
(NMJ) – has been examined extensively over the past sev-
eral decades. Enriched in the postsynaptic domain of the
NMJ are ion channels named acetylcholine (ACh) recep-
tors (AChRs) that open upon binding to the neurotrans-
mitter ACh; opening of AChRs depolarizes the synaptic
region of muscle to trigger contraction. The synaptic
aggregation of AChRs during NMJ assembly is therefore a
process of paramount importance, one that is recognized
to be tightly controlled by the combined actions of both
muscle- and nerve-derived factors.
AChR clustering in muscle is initiated by the activation of
the receptor tyrosine kinase MuSK (muscle-specific
kinase) and it is mediated by the cytoplasmic protein rap-
syn that binds to AChRs and tethers them to the cytoskel-
eton [1-3]. During development, rudimentary AChR
clusters first appear before innervation in a MuSK-
dependent manner and bestride the midline of embryonic
muscle fibers [4,5]; these clusters are referred to as "pre-
patterned" clusters because they form in the absence of
neural influence. Later, in innervated muscle, AChRs
become concentrated at incipient synapses where MuSK is
locally stimulated by the nerve-derived factor agrin [4-6].
This synaptic accumulation of AChRs is furthermore cou-
pled with the disassembly of the pre-patterned AChR clus-
ters [7-10], and these two distinct processes together help
generate a 1000-fold higher density of AChRs at the NMJ
compared to extra-synaptic muscle [11].
The disassembly of pre-patterned AChR clusters, which is
our focus here, was first shown to occur independently of
AChR activity [7-10]; however, it was also reported that in
rat and chick myotubes AChR agonists trigger the loss of
AChR clusters [12,13], an issue that has recently attracted
renewed attention. It has been observed that pre-pat-
terned AChR aggregates, which are eliminated by embry-
onic day 17 or 18 (E17-18) in innervated muscle fibers of
normal mice, are retained in the muscles of mutant mice
with defective motor innervation [4,5] and of mice lack-
ing the gene encoding the ACh biosynthetic enzyme
choline acetyltransferase (CHAT) [14,15]. These findings
have engendered the view that ACh directs the disassem-
bly of AChR aggregates, and it has been proposed that
neural agrin protects synaptic AChRs against ACh-
induced dispersal [16]. The dispersal of AChR clusters by
ACh is further thought to involve the ser/thr kinase Cdk5
[17,18] whose activity, in turn, appears to depend on the
regulation of the protease calpain by rapsyn [19].
AChR activity-independent AChR dispersal has been well
documented in frog and fish muscle where synaptogenic
stimuli trigger both the assembly and disassembly of
AChR aggregates [7,9,10,20-22]. In our studies we have
used embryonic Xenopus muscle cultures to focus on the
regulation of the AChR dispersal process by tyrosine phos-
phatases [23-25] because it is known that tyrosine phos-
phorylation stabilizes AChR clusters by strengthening
links between AChRs and the actin cytoskeleton [26-31].
We showed that tyrosine phosphatases mediate the dis-
persal of pre-patterned AChR clusters by synaptogenic
stimuli and that tyrosine dephosphorylation of pre-pat-
terned clusters precedes the loss of AChRs from these sites
in situ [2,23-25,32]. To date, however, the specific phos-
phatases involved in dispersing AChR clusters and the sig-
naling pathways that stimulate them have remained
unknown. These issues were addressed here using phar-
macological and molecular methods and we describe for
the first time a role of the tyrosine phosphatase Shp2, and
its activator signal regulatory protein α1 (SIRPα1), in the
disassembly of pre-patterned AChR clusters.
Methods
Reagents
Recombinant heparan-binding growth associated mole-
cule (HB-GAM) was generously provided by Dr. Heikki
Rauvala (University of Helsinki). Neural agrin was
obtained as described [33]. The following reagents were
purchased: NSC-87877 (Acros Organics; Fairlawn, NJ);
tetramethylrhodamine-conjugated  α-bungarotoxin (R-
BTX) (Molecular Probes; Eugene, OR); anti-phosphotyro-
sine (mAb4G10) and anti-STEP tyrosine phosphatase
monoclonal antibodies (Upstate Biotechnology; Lake
Placid, NY); anti-Shp2 monoclonal antibody and protein
tyrosine phosphatase antibody kit (BD Biosciences; San
Jose, CA); secondary antibodies conjugated to FITC
(Zymed; South San Francisco, CA) and horseradish-perox-
idase (HRP) (Jackson Immuno Research Laboratories, Inc;
West Grove, PA); Triton X-100 (TX-100) (Pierce; Rock-
ford, IL).
Whole-mount in situ hybridization
Xenopus embryos collected at different developmental
stages were fixed in MEMFA solution (0.1 M MOPS, pH
7.4, with 2 mM EGTA, 1 mM MgSO4, and 3.7% formalde-
hyde) for 2 h at room temperature and then stored in
absolute methanol at -20°C. Embryos were re-hydrated
through a graded methanol series before carrying out in
situ hybridization as described [34]. The cDNA encoding
Xenopus SH2 domain-containing tyrosine phosphatase
Shp2 in pCS2+ vector was kindly provided by Dr. Ben-
jamin Neel (Beth Israel Deaconess Medical Center). ThisBMC Neuroscience 2008, 9:70 http://www.biomedcentral.com/1471-2202/9/70
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was used to synthesize digoxigenin-labeled cRNA probes
in the antisense and sense directions with SP6 and T3 RNA
polymerases with the Riboprobe In Vitro Transcription kit
(Promega; Madison, WI). Hybridization reactions were
carried out in parallel with these probes at a concentration
of 0.1 μg/ml (in the presence of 1 mg/ml Torula RNA)
overnight at ~60°C. Embryos were washed extensively
with several buffers, including those containing RNaseA
(20 μg/ml) and RNase T1 (10 U/ml), and then stained
overnight at 4°C with alkaline phosphatase-linked anti-
digoxigenin antibody. Chromogenic reaction was carried
out by using NBT/BCIP as substrate in the alkaline phos-
phatase buffer (100 mM Tris HCL, 50 mM MgCl2, 100
mM NaCl, 0.1% Tween-20, 5 mM levamisol). Embryos
were made transparent with a 2:1 mixture of benzyl benx-
oate:benzyl alcohol and imaged using a color CCD cam-
era.
Protein extract preparation and immuno-blotting
C2 mouse myoblasts (American Type Culture Collection)
were differentiated into myotubes (4–5 d) and proteins
were extracted from them using a TX-100 buffer (100 mM
Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% TX-100, and
1 mM Na-pervanadate; 1 ml buffer/10 cm dish) as
described [25]. To extract Xenopus embryonic muscle pro-
teins, dissected tadpole tails were homogenized in the
above Triton buffer and the homogenates were incubated
for 30 min on ice (with frequent mixing) before centrifug-
ing them to obtain clarified extracts. Proteins were
resolved by SDS-polyacrylamide gel electrophoresis and
transferred to PVDF membranes, which were blocked in
Tris-buffered saline containing 0.1% Tween-20 and 5%
milk and immuno-blotted with antibodies diluted in the
same blocking buffer. Primary antibodies were detected
using appropriate HRP-linked secondary antibodies and
enhanced chemiluminescence substrate (West Pico,
Pierce).
Shp2 and SIRPα1 cDNA constructs and mRNA synthesis
Human wild-type and mutant Shp2 cDNA constructs
were from Dr. Benjamin Neel (Beth Israel Deaconess
Medical Center). The mutant Shp2s were Shp2 E76A,
which has a point mutation in the N-SH2 domain and
produces a constitutively active Shp2 [35], and Shp2 del-
taP, which has a deletion in the catalytic domain and,
lacking both catalytic activity and substrate-binding abil-
ity, acts as a dominant-negative mutant [36]. Wild-type
Shp2 (Shp2 WT), Shp2 E76A and Shp2 deltaP cDNAs
were cloned into pSP64R1 vector [35]. Human full-length
SIRPα1 (SIRP-FL) and truncated SIRPα1 (SIRP-TR) con-
structs were from Dr. David Clemmons (University of
North Carolina at Chapel Hill). In SIRP-TR, the Y475 site
of the tandem phosphorylation domain of SIRPα1 that
binds to Shp2 is eliminated, generating a SIRPα1 mutant
that does not activate Shp2 and functions as a dominant-
negative suppressor of Shp2 signaling [37]. SIRPα1
sequences were in pcDNA3.1 vector [37] as were those
encoding the reporter green fluorescent protein (GFP).
Shp2 mRNAs were prepared with the SP6 in vitro tran-
scription kit purchased from Ambion (Austin, TX) and the
SIRPα1 and GFP mRNAs were prepared with the T7
ULTRA kit from the same company. Shp2 and SIRPα1
mRNAs were mixed with GFP mRNA before microinjec-
tion.
Xenopus embryo microinjection and preparation of 
primary muscle cultures
Mixtures of Shp2 or SIRPα1 and GFP mRNAs (total 10 ng
or less, in a volume of 4.6–9.2 nl) were injected into one
cell of 2–4 cell stage Xenopus embryos with a Drummond
Nanoject oocyte injector (Drummond Scientific Co.,
Broomall, PA). Injected embryos were maintained in
Holfreter's solution containing 4% Ficoll and those
expressing exogenous mRNAs were identified by green
fluorescence and used for preparing muscle cultures [38].
Myotomal muscle cells were cultured from stage 20–22
embryos as described [39] and plated on glass coverslips
coated with ECL (entactin-collagen IV-laminin) substrate
(Upstate Biotechnology). AChR redistribution experi-
ments used muscle cells maintained in culture for 2–6
days.
Shp2-inhibitor, R-BTX/antibody labeling and microscopy
The Shp2-inhibitor NSC-87877 [40] was dissolved in
water and then diluted into culture medium as required.
R-BTX-labeled muscle cells were incubated in culture
medium without or with NSC-87877, in the absence or
presence of agrin or HB-GAM beads. Polystyrene beads
(10 μm; Polysciences, Warrington, PA) were coated with
HB-GAM as described [41]. In cases where muscle cells
expressed exogenous mRNAs, live cultures were used to
examine cells of comparable GFP fluorescence intensity
and AChR cluster redistribution data were collected from
a minimum of five separate mRNA injections and culture
preparations. In experiments using wild-type cultures,
muscle cells were fixed with cold 95% ethanol and stained
with primary and fluorescent secondary antibodies.
Labeled cells were imaged using an Olympus IX70 micro-
scope equipped with a Hamamatsu ORCAII cooled-CCD
or ORCA-ER camera controlled by MetaMorph software
(Universal Imaging, West Chester, PA).
Results
Shp2 expression in Xenopus embryonic muscle
We previously reported that Shp2, a tyrosine phosphatase
with two SH2 domains [42], modulates AChR clustering
in C2 mouse myotubes by suppressing agrin/MuSK sign-
aling [25,43], but whether or not Shp2 (or a different
phosphatase) participates in the dispersal of pre-pat-
terned AChR clusters by synaptogenic stimuli could notBMC Neuroscience 2008, 9:70 http://www.biomedcentral.com/1471-2202/9/70
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be tested. This is because in the C2 myotube cultures very
few pre-patterned AChR clusters developed and those that
did form resembled new clusters induced by agrin. Thus,
to investigate tyrosine phosphatase involvement specifi-
cally in the disassembly of AChR clusters, here we used
primary cultures of embryonic Xenopus muscle cells in
which the dispersal of pre-patterned AChR clusters by syn-
aptogenic stimuli can be examined separately from the
induction of new AChR clusters and both processes can be
quantified (see below) [23-25]. We began by staining the
myotomal muscle cell cultures with antibodies against
twelve different tyrosine phosphatases and found that an
anti-Shp2 antibody, unlike other antibodies tested,
labeled the cells strongly and uniformly (unpublished
observations), which led us to determine if Shp2 was
present in embryonic Xenopus muscle in vivo. Whole
mount in situ hybridization was carried out with an anti-
sense digoxigenin-labeled RNA probe made from Xeno-
pus Shp2 cDNA, and the results showed that Shp2 mRNA
was enriched in the brains and myotomes of embryos at
stages 22 and 28 (Figure 1A). The detection of Shp2
mRNA was specific as no hybridization occurred with a
control sense probe (panel B). Moreover, in immuno-
blotting assays using tadpole tail extracts, an anti-Shp2
monoclonal antibody stained a single protein band of the
size expected for Shp2 (~70 kD), and the antibody also
stained a band of similar size in C2 mouse myotube
extracts (Figure 1C). These results combined with previ-
ous demonstrations of Shp2 expression in rodent muscle
cells [25,44] identified Shp2 as a candidate tyrosine phos-
phatase involved in the dispersal of pre-patterned AChR
clusters.
Shp2 inhibition and AChR cluster dispersal
To test whether Shp2 activity influences the dispersal of
pre-patterned AChR clusters during NMJ formation, we
exposed cultured Xenopus muscle cells to NSC-87877, a
recently identified chemical inhibitor of Shp2 [40]. Cells
were stained with rhodamine-conjugated α-bungarotoxin
(R-BTX) to label AChRs and incubated overnight without
or with the drug. First, in the absence of synaptogenic
stimulation, small AChR clusters (0.5–2 μm in diameter)
developed in many of the NSC-treated but not control
cells (Figure 2A–D); normal, pre-patterned clusters (see
below) were detected in both NSC-treated and control
cells. When used at 1 μM, NSC-87877 nearly doubled the
percentage of muscle cells with AChR micro-clusters (Fig-
ure 2E), and at higher concentrations of NSC (10 μM or
more) there appeared to be a further increase (~50%) in
AChR clustering (data not shown). In the 0.1–2 μM range,
NSC-87877 is likely to inhibit (other than Shp2) Shp1
(IC50 ~0.3 μM) and to a lesser extent PTP1B (IC50 ~1.7
μM), but at high concentrations other phosphatases could
be affected [40]. As no significant staining of Xenopus
muscle cells was detected using either the anti-Shp1 or
anti-PTP1B antibody, it is possible that at a concentration
of 1 μM NSC's primary target in these cells is Shp2. More-
over, unlike NSC, several control drugs against proteins
unrelated to Shp2 had no effect on AChR clustering
(unpublished observations) [25,32].
The above results and those showing enhanced AChR
clustering in C2 mouse myotubes following the depletion
or inhibition of Shp2 [25,43] support the conclusion that
in Xenopus muscle cells, as in mouse myotubes, Shp2
limits the formation of AChR clusters. But does Shp2 also
mediate the dispersal of pre-patterned AChR clusters? To
answer this we again used NSC-treatment and examined
the AChR clusters that form spontaneously in Xenopus
muscle cells that have been in culture for 2 or more days.
These large AChR clusters, which are often more than 10–
15 μm across and were previously referred as "hot spots",
were the ones considered here to be "pre-patterned"
because they develop without synaptogenic stimulation.
These pre-patterned clusters are stable for several days and
do not disperse on their own, but they are rapidly disas-
sembled when muscle cells are innervated by co-cultured
nerves or when the cells are exposed to agrin or growth
Shp2 expression in embryonic Xenopus muscle Figure 1
Shp2 expression in embryonic Xenopus muscle. In situ 
hybridization assays for Shp2 mRNA were carried out with 
anti-sense (A) and control sense (B) probes using stage 22 (A 
and B, upper) and 28 (lower) Xenopus embryos. Specific 
labeling was observed with Shp2 mRNA anti-sense probe in 
myotomal muscle and brain. C. TX-100 total protein 
extracts of Xenopus tadpole tail muscle ("X") and cultured 
C2 myotubes ("C") were immunoblotted with an anti-Shp2 
monoclonal antibody. A band of about 70 kD was observed 
in both samples. Positions of molecular weight markers are 
indicated on the left.BMC Neuroscience 2008, 9:70 http://www.biomedcentral.com/1471-2202/9/70
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Effect of Shp2 inhibitor NSC-87877 on AChR micro-cluster formation Figure 2
Effect of Shp2 inhibitor NSC-87877 on AChR micro-cluster formation. Cultured Xenopus muscle cells, used here 
and in all experiments described below, were labeled with R-BTX and then incubated overnight in control culture medium (A, 
B) or in medium containing 1 μM NSC-87877 (NSC) (C, D). Large pre-patterned AChR clusters, often >10 μm in width, were 
detected in both control and NSC-treated cells (B, D; large arrows), but in cells exposed to NSC, AChR micro-clusters were 
also frequently observed (D; small arrows). E. Quantification of pooled data from multiple experiments revealed that AChR 
micro-clusters developed in nearly twice the number of muscle cells incubated in 1 μM NSC-87877 as those maintained in con-
trol medium. Mean and SEM values are shown here and in all following figures; control cells, n = 103; NSC-treated cells, n = 
109; t-test *p < 0.005.BMC Neuroscience 2008, 9:70 http://www.biomedcentral.com/1471-2202/9/70
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factor-coated beads [23-25]. We have previously demon-
strated that the rate of dispersal of a pre-patterned cluster
is directly related to its distance from a synaptogenic stim-
ulation site as well as to the strength of the external stim-
ulus [10,23]. In all experiments described below, muscle
cells were labeled with R-BTX before synaptogenic stimu-
lation so that the true disassembly of pre-patterned clus-
ters could be followed, and, in all cases, untreated
(control) cells from the same culture preparation were
examined in parallel to confirm that pre-patterned clus-
ters had developed normally. These control cells addition-
ally showed that during the course of the assays (none of
which lasted longer than one day) there was no significant
increase in spontaneous AChR clustering, which is in
accord with our previous work [10]. This point is impor-
tant to consider because the rapid, net decrease in the
number of pre-patterned AChR clusters that follows syn-
aptogenic stimulation demonstrates that external stimuli
actively disperse old AChRs clusters rather than merely
preventing (if this occurs at all) the assembly of addi-
tional, new pre-patterned clusters (leaving the original
pre-patterned clusters intact). Indeed, we have previously
used growth factor-coated beads and time-lapse imaging
of identified pre-patterned clusters to show their dispersal
by applied stimuli in live cells [23]. Lastly, in this study
pure muscle cultures were used throughout to avoid any
(currently unknown) presynaptic effect of NSC-87877
that could potentially influence AChR redistribution in
nerve-muscle co-cultures.
In R-BTX-labeled muscle cells, overnight treatment with
agrin generated AChR micro-clusters (~0.5–2 μm) and
triggered the loss of pre-patterned clusters (Figure 3A–B)
as described before [25,33]; in the absence of agrin pre-
patterned clusters remained unaffected (as in Fig. 2; con-
trol). In contrast, in muscle cells exposed to agrin plus
NSC-87877, both small AChR clusters and the larger
aggregates resembling pre-patterned AChR clusters were
detected (panels C-D). Similarly, small and large AChR
clusters were present on the surface of muscle cells treated
with agrin and the tyrosine phosphatase inhibitor per-
vanadate (panels E-F) as shown previously [23-25]. These
results suggested that agrin-dependent dispersal of pre-
patterned AChR clusters was blocked by the inhibition of
Shp2.
To accurately quantify NSC's effect on dispersal, we stim-
ulated muscle cells with beads coated with heparan-bind-
ing growth-associated molecule (HB-GAM), which induce
clusters of AChRs associated with proteins that are also
found at nerve-muscle synapses and AChR clusters gener-
ated by agrin [2,24]. These beads generate AChR clusters
only at sites where they directly contact muscle cells,
which eliminates any chance of mistaking induced AChR
clusters for pre-patterned ones [23,25,41], and the ability
to count separately these dissimilar (bead-induced and
pre-patterned) clusters makes it possible to easily distin-
guish an increase of spontaneous AChR clustering caused
by a drug-treatment (perhaps by disinhibition of cluster
formation) from the inhibition of cluster disassembly (see
below). Following overnight stimulation with HB-GAM
beads, AChR clusters were found at bead-muscle contacts
in both control and NSC-treated cells, but unlike in con-
trol cells, in NSC-treated cells pre-patterned AChR clusters
were also readily detected (Figure 4A–D). We determined
the percentage of beads that induced new AChR clusters
and counted the pre-patterned AChR clusters that were
present on cells after exposure to beads. The latter num-
bers were then normalized relative to those obtained from
untreated and NSC-treated cells examined in parallel to
which beads had not been added – this was done to com-
pensate for any potential change (however small) in the
number of pre-patterned clusters that might have arisen
during the assay period. Our pooled data showed that
NSC-treatment inhibited bead-stimulated dispersal of
pre-patterned AChR clusters (Figure 4E) but not the
induction of new AChR clusters (panel F). These results
also indicated that cluster dispersal was not blocked due
to an inability of the beads to initiate signaling per se in
the presence of the Shp2-inhibitor. This selective inhibi-
tion of dispersal by NSC-addition is akin to what is
observed when muscle cells are exposed to pervanadate,
but it differs from the effects of other compounds that
either do not influence dispersal or which suppress disper-
sal by blocking synaptogenic signaling [23,25,32,45].
To directly evaluate NSC-87877's effect on the AChR clus-
ter disassembly process, muscle cells were stimulated with
HB-GAM beads for 4 h and stained with a monoclonal
antibody against phosphotyrosine (mAb4G10). Because
the loss of phosphotyrosine labeling precedes the deple-
tion of AChRs from moribund pre-patterned clusters, the
phosphorylation state of AChR-containing clusters (i.e.,
the fractional area of a pre-patterned AChR cluster labeled
by anti-phosphotyrosine) can be used to measure the
spread of the dispersal signal [25]. When we examined the
phosphorylation of pre-patterned AChR clusters in mus-
cle cells in which beads had induced new AChR clusters,
the pre-patterned clusters in control cells were found to be
tyrosine dephosphorylated significantly more (Figure 5A–
C) than those in NSC-treated cells (panels D-F). In the
examples shown (Fig. 5), the pre-patterned AChR cluster
in the control muscle cell is devoid of phosphotyrosine
whereas the one in the NSC-treated cell has lost but a tithe
of its phosphotyrosine. Pooled data were quantified by
sorting pre-patterned AChR clusters in bead-stimulated
cells (both control and NSC-treated) as being fully tyro-
sine phosphorylated, partially dephosphorylated (where
labeling for phosphotyrosine overlapped with less than
half of that for AChRs) and completely dephosphorylatedBMC Neuroscience 2008, 9:70 http://www.biomedcentral.com/1471-2202/9/70
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Effect of NSC-87877 on agrin-induced dispersal of pre-patterned AChR clusters Figure 3
Effect of NSC-87877 on agrin-induced dispersal of pre-patterned AChR clusters. Muscle cells labeled with R-BTX 
were incubated overnight in culture medium containing agrin (ctl; A, B), agrin plus 2 μM NSC-87877 (NSC; C, D), or agrin plus 
20 μM pervanadate (PV; E, F). In agrin-treated muscle cells AChR micro-clusters (~0.5–2 mm in diameter) were found but 
larger clusters were not generally detected (B). However, in cells incubated with agrin and NSC (D) or agrin and PV (F), both 
micro-clusters and large pre-patterned clusters were present (arrows).BMC Neuroscience 2008, 9:70 http://www.biomedcentral.com/1471-2202/9/70
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Inhibition of HB-GAM bead-induced dispersal of pre-patterned AChR clusters by NSC-87877 Figure 4
Inhibition of HB-GAM bead-induced dispersal of pre-patterned AChR clusters by NSC-87877. R-BTX-labeled 
muscle cells were stimulated overnight with HB-GAM beads in the absence (A, B) or presence of 1 μM NSC-87877 (C, D). In 
control cells only bead-induced AChR clusters were present (B; asterisks) but in the NSC-treated cells both bead-induced (D; 
asterisks) and pre-patterned AChR clusters (arrows) were detected. The number of pre-patterned AChR clusters in bead-
stimulated cells and the fraction of beads that induced new AChR clusters were quantified from multiple experiments using 0.1 
or 1 μM NSC and the results were normalized relative to cells maintained in control medium (E, F). NSC-treatment inhibited 
the dispersal of pre-patterned AChR clusters but did not significantly affect the induction of new AChR clusters by HB-GAM 
beads. Control, n = 95; 0.1 μM NSC, n = 115; 1 μM NSC, n = 129; *p < 0.05, 1 μM NSC relative to control.BMC Neuroscience 2008, 9:70 http://www.biomedcentral.com/1471-2202/9/70
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Blockage of tyrosine dephosphorylation of pre-patterned AChR clusters by NSC-treatment Figure 5
Blockage of tyrosine dephosphorylation of pre-patterned AChR clusters by NSC-treatment. R-BTX-labeled mus-
cle cells were exposed to HB-GAM beads for 4 h in the absence (A-C) or presence of 1 μM NSC-87877 (D-F), fixed and then 
stained with anti-phosphotyrosine (mAb4G10) and FITC-conjugated secondary antibodies. In the example of the control mus-
cle cell shown here, phosphotyrosine is detected at the bead-induced cluster (B, C; asterisks) but not at the pre-patterned 
cluster (B, C; arrow), but in the NSC-treated muscle cell, both the bead-induced cluster (E, F: asterisks) and the pre-patterned 
cluster (E, F: arrows) contain phosphotyrosine. G. Pooled data from multiple experiments were quantified after sorting the 
pre-patterned AChR clusters present on bead-stimulated cells as being fully tyrosine phosphorylated or partially or fully 
dephosphorylated. Control, n = 127; 0.1 μM NSC, n = 129; 1 μM NSC, n = 94; *p < 0.05 NSC relative to control.BMC Neuroscience 2008, 9:70 http://www.biomedcentral.com/1471-2202/9/70
Page 10 of 17
(page number not for citation purposes)
(where no phosphotyrosine enrichment was detected at
AChR clusters). These results indicated that Shp2-inhibi-
tion hindered the spread of the AChR cluster dispersing
signal (panel G).
The above NSC-87877 data suggest that Shp2 signaling
promotes the disassembly of pre-patterned AChR clusters,
which agrees with and extends our earlier finding that
tyrosine phosphatase activity mediates AChR cluster dis-
persal [2,23,25].
Exogenous Shp2 expression and AChR cluster dispersal
To investigate Shp2's influence on AChR cluster dispersal
using a different approach, we next examined muscle cells
expressing exogenous Shp2 proteins. For this, mRNAs
encoding wild-type Shp2 (Shp2 WT), constitutively active
Shp2 (Shp2 E76A) or inactive Shp2 (Shp2 deltaP) and the
reporter green fluorescent protein (GFP) were injected
into Xenopus embryos from which muscle cells were cul-
tured. AChRs were labeled with R-BTX and cells with exog-
enous proteins were identified by green fluorescence. In
muscle cells expressing wild-type or constitutively active
Shp2, fewer pre-patterned AChR clusters were found than
in cells expressing GFP alone (Figure 6A–F; quantified in
panel G), suggesting that Shp2 inhibited the formation of
AChR clusters in these muscle cells as in C2 myotubes
[25,43]. Moreover, after stimulation with HB-GAM beads,
more complete dispersal of pre-patterned AChR clusters
occurred in muscle cells expressing wild-type or constitu-
tively active Shp2 compared to those expressing GFP only
(Figure 7A–I). To quantify these data, we divided the
number of pre-patterned AChR clusters in bead-stimu-
lated cells (expressing GFP or GFP plus Shp2 proteins) by
the number of pre-patterned clusters in cells not exposed
to beads (as described in the previous section); here, this
compensated for the reduced formation of pre-patterned
AChR clusters in cells over-expressing Shp2. These ratios
were then further normalized using those calculated for
cells expressing GFP alone. These results indicated that the
presence of excess wild-type or constitutively active Shp2
proteins in muscle cells is sufficient for promoting AChR
cluster dispersal (Figure 7J). In these assays the exogenous
Shp2 proteins did not block the induction of new AChR
clusters (panel K) suggesting that higher Shp2 activity
and/or the activity of additional tyrosine phosphatases is
required to inhibit AChR clustering by HB-GAM beads.
Here we also tested whether ectopic expression of the
inactive Shp2 in Xenopus muscle cells would significantly
hinder AChR cluster dispersal and found that not to be the
case (images not shown; see quantified data in Figures 6,
7). This is possibly because we obtained only low-level
expression of inactive Shp2 in cells (as indicated by GFP
fluorescence) and attempts to enhance this mutant's
expression by injecting more of its mRNA into embryos
disrupted development as previously noted [35,36]. That
Shp2 signaling plays a role in mediating the dispersal of
AChR clusters, however, is suggested by experiments
described below using the Shp2-activator SIRPα1 and a
mutant form of it.
SIRPα1 over-expression and AChR cluster dispersal
SIRPα1 is a transmembrane protein that, when tyrosine-
phosphorylated, binds to Shp2's tandem SH2 domains
and stimulates Shp2 activity [42]. We recently showed
that in C2 mouse myotubes SIRPα1's tyrosine phosphor-
ylation and Shp2-binding were enhanced by agrin-treat-
ment and that increased SIRPα1/Shp2 signaling inhibited
AChR cluster formation [43]. To test whether SIRPα1/
Shp2 signaling also regulates AChR cluster dispersal, we
injected Xenopus embryos with mRNAs encoding full-
length SIRPα1 (SIRP-FL), which can stimulate Shp2, or
truncated SIRPα1 (SIRP-TR), which lacks the Shp2-bind-
ing tyrosine phosphorylation domain and acts as a domi-
nant-negative suppressor of Shp2 signaling in cells [37].
Muscle cells expressing GFP or GFP and the SIRPα1 pro-
teins were exposed to HB-GAM beads and the number of
pre-patterned AChR clusters remaining after stimulation
was determined, divided by the number obtained from
the cells not exposed to beads, and normalized relative to
the value calculated for GFP-cells (as discussed above).
Compared to the expression of GFP only (Figure 8A–C),
expression of full-length SIRPα1 in muscle cells signifi-
cantly enhanced pre-patterned AChR cluster dispersal by
beads (panels D-F) whereas the expression of truncated
SIRPα1 inhibited dispersal (panels G-I). These effects,
quantified in panel J, were produced specifically by
SIRPα1: in contrast to full-length SIRPα1, expression of a
different phosphoprotein, p120 catenin (p120ctn), did
not promote AChR cluster dispersal, and unlike truncated
SIRPα1, phospho-mutant p120ctn did not block AChR
redistribution [38]. Taken together with our Shp2 results,
these findings suggest that full-length SIRPα1 accelerated
AChR cluster dispersal by activating endogenous Shp2
and that truncated SIRPα1 suppressed dispersal by reduc-
ing the ability of endogenous signaling intermediates
(SIRPα1 or related proteins) to activate Shp2 in response
to synaptogenic stimuli.
Discussion
The disassembly of pre-patterned AChR clusters that
occurs in muscle following motor innervation facilitates
selective AChR concentration at the NMJ. Here we studied
the process by which AChR clusters are disassembled by
synaptogenic stimuli using primary cultures of Xenopus
muscle cells. We found that AChR cluster dispersal was
expedited when active or activatable Shp2, or the Shp2-
activator SIRPα1, was introduced into muscle cells, but
that cluster dispersal was blocked when cells were exposed
to an inhibitor of Shp2 or when they over-expressed aBMC Neuroscience 2008, 9:70 http://www.biomedcentral.com/1471-2202/9/70
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Effects of over-expression of wild-type or constitutively active Shp2 on pre-patterned AChR cluster formation Figure 6
Effects of over-expression of wild-type or constitutively active Shp2 on pre-patterned AChR cluster formation. 
Wild-type and mutant Shp2 proteins were over-expressed in Xenopus muscle cells by mRNA injection. Muscle cells expressing 
green fluorescent protein alone (GFP; A, B) or GFP together with wild-type Shp2 (Shp2 WT; C, D), constitutively active Shp2 
(Shp2 E76A; E, F) or dominant-negative Shp2 (Shp2 deltaP; images not shown) were stained with R-BTX (B, D, F) to visualize 
pre-patterned AChR clusters. In muscle cells expressing GFP, normal pre-patterned AChR clusters were found (B; arrow), but 
in cells with wild-type or constitutively active Shp2 fewer clusters were detected (D, F). G. Data from multiple micro-injection 
experiments were quantified and the numbers of pre-patterned clusters in cells expressing wild-type and active Shp2 were nor-
malized relative to the number obtained from GFP-expressing cells. GFP-cells, n = 356; Shp2 WT, n = 98; Shp2 E76A, n = 327; 
Shp2 deltaP, n = 356; *p < 0.05; **p < 0.001 relative to GFP-cells.BMC Neuroscience 2008, 9:70 http://www.biomedcentral.com/1471-2202/9/70
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mutant form of SIRPα1 that curbs Shp2 signaling. These
results suggest that Shp2 and its regulators such as SIRPα1
promote the disassembly of pre-patterned AChR clusters
by synaptogenic stimuli during NMJ development.
Innervation of muscle triggers AChR concentration at the
NMJ. For this to occur, three proteins are indispensable:
rapsyn, for clustering AChRs [46], MuSK, for initiating the
AChR aggregation process [47], and agrin, for enabling
synaptic AChR accumulation [16,48]. AChR clusters are
further stabilized by tyrosine kinases [29,30,49] and the
dystrophin complex proteins [50] that directly or indi-
rectly strengthen AChR-cytoskeleton linkage. Moreover,
AChR clustering requires dynamic actin polymerization
[45], which is regulated by small GTPases, their effectors
and other modulators [51-54], and clustering is also pro-
Acceleration in the dispersal of pre-patterned AChR clusters resulting from exogenous wild-type or constitutively active Shp2  expression Figure 7
Acceleration in the dispersal of pre-patterned AChR clusters resulting from exogenous wild-type or constitu-
tively active Shp2 expression. R-BTX labeled muscle cells expressing GFP only (A-C), or GFP plus Shp2 WT (D-F), Shp2 
E76A (E-G) or Shp2 deltaP (not shown) were stimulated overnight with HB-GAM beads. In a fraction of bead-stimulated cells 
expressing GFP alone, pre-patterned AChR clusters were still present, but the fraction of such cells expressing wild-type or 
active Shp2 that retained pre-patterned clusters was significantly lower. To quantify these results, the number of pre-patterned 
clusters counted in bead-stimulated cells was divided by the number obtained from muscle cells that had not been exposed to 
beads (to offset differences in pre-patterned cluster formation; see text). Results normalized relative to GFP-cells are shown in 
panel J. GFP-cells, n = 212; Shp2 WT, n = 60; Shp2 E76A, n = 138; Shp2 deltaP, n = 127; *p < 0.01; **p < 0.05. Panel K shows 
that the expression of Shp2 proteins did not affect bead-induced AChR clustering.BMC Neuroscience 2008, 9:70 http://www.biomedcentral.com/1471-2202/9/70
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SIRPα1's regulation of pre-patterned AChR cluster dispersal Figure 8
SIRPα1's regulation of pre-patterned AChR cluster dispersal. R-BTX labeled muscle cells expressing GFP alone (A-C) 
or GFP and wild-type SIRPα1 (SIRP-FL; D-F) or dominant-negative SIRPα1 (SIRP-TR, G-I) were exposed to HB-GAM beads 
overnight. In the muscle cell expressing dominant-negative SIRPα1, a large pre-patterned AChR cluster was detected (I; arrow) 
in addition to the bead-induced clusters, which were present in control and Shp2-expressing cells (C, F, I; asterisks). Results, 
quantified as described in Fig. 7, revealed that the expression of wild-type SIRPα1 promoted the dispersal of pre-patterned 
AChR clusters whereas expression of dominant-negative SIRPα1 inhibited dispersal (panel J). GFP-cells, n = 198; SIRP-FL, n = 
156; SIRP-TR, n = 169; *p < 0.05 relative to GFP-cells.BMC Neuroscience 2008, 9:70 http://www.biomedcentral.com/1471-2202/9/70
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moted by a transmembrane protein, LRP4 [55], and the
MuSK-binder, dok-7 [56].
In addition to AChR aggregation, innervation triggers the
dispersal of pre-patterned AChR clusters. In Xenopus pri-
mary muscle cultures these two processes can be readily
distinguished from one another and the redistribution of
AChRs in response to various stimuli can be accurately
quantified [23,25,32,41]. We have previously shown that
tyrosine phosphatases mediate AChR cluster dispersal
[23,25] and here we identified Shp2 as one of the phos-
phatases that facilitates dispersal. Treatment of muscle
cells with NSC-87877, a selective Shp2 antagonist [40],
hindered the dispersal of pre-patterned AChR clusters
without preventing the induction of new AChR clusters, as
also seen with the general phosphatase inhibitor pervana-
date but not other drugs [23,25,32,45].
NSC-treatment enhanced AChR clustering in Xenopus
muscle cells whereas the expression of active Shp2 had the
opposite effect, consistent with our results in C2 myo-
tubes [43]. In C2 myotubes, however, the expression of
dominant-negative Shp2 promoted AChR cluster forma-
tion [43] but here no significant effect of this mutant on
cluster induction was detected. Additionally, because the
inactive Shp2 mutant was only poorly expressed in Xeno-
pus muscle cells, we could not test whether "dominant-
negative" inhibition of Shp2 would block AChR cluster
dispersal, as suggested by our pharmacological assays. But
because Shp2-dependent suppression of AChR clustering
in C2 myotubes could be stimulated by the phosphopro-
tein SIRPα1 [43], we examined if exogenous SIRPα1 pro-
teins can affect the dispersal of pre-patterned AChR
clusters in Xenopus muscle cells. Expression of full-length
and truncated SIRPα1, which enhance and inhibit Shp2
signaling [37], promoted and blocked AChR cluster dis-
persal, respectively. These results suggest that SIRPα1 (or
a protein related to it) spreads the signal that globally acti-
vates Shp2 to facilitate AChR cluster disassembly.
While our results have revealed a novel role of SIRPα1 and
Shp2 in AChR dispersal, it is likely that other, as yet uni-
dentified proteins are also involved. This is because inhi-
bition of all tyrosine phosphatases with pervanadate
blocks AChR cluster disassembly more effectively [23]
than reagents that target SIRPα1 and Shp2. However, our
current and previous findings suggest a signaling pathway
for SIRPα1/Shp2-dependent dispersal of AChR clusters in
response to a synaptogenic stimulus. Near innervation
sites, for example, Shp2 activated by SIRPα1 in response
to agrin-stimulation of MuSK could, in addition to curtail-
ing the AChR clustering signal [25,43], dephosphorylate
and increase the activity of src kinases [57] in the sur-
rounding area to trigger more SIRPα1 phosphorylation
and Shp2 activation, and so on (Figure 9). Such a "regen-
erative" signaling pathway with src, SIRPα1, and Shp2
functioning sequentially was described in integrin signal-
ing [58] where it was shown that phosphorylation of
SIRPα1 leads to the activation of Shp2, which stimulates
src that phosphorylates SIRPα1. Because AChR clusters
induced in muscle cells by growth factor-coated beads and
agrin contain a similar complement of signaling and scaf-
folding proteins [2,24], it is possible that many of the
same molecules activated following direct or indirect
MuSK stimulation regulate the src, SIRPα1 and Shp2 sig-
naling cascade. A spread of this signaling across muscle
could trigger Shp2 to dephosphorylate AChR-associated
proteins at pre-patterned clusters or AChRs themselves,
which are in vitro substrates of Shp2 [59]; dephosphoryla-
tion of AChRs and/or other denizens of the pre-patterned
clusters could then de-link AChRs from the cytoskeleton
[31] and allow their redistribution.
Several studies (in addition to ours) have demonstrated
that pre-patterned AChR cluster disassembly occurs in
amphibian and fish muscle independently of AChR activ-
ity. For example, in Xenopus muscle cells, pre-patterned
clusters are dispersed by innervation when all AChR chan-
A model for Shp2-dependent regulation of AChR redistribu- tion Figure 9
A model for Shp2-dependent regulation of AChR 
redistribution. Synaptogenic stimuli initiate two SIRPα1/
Shp2-involving signaling cascades. Agrin/MuSK stimulates src 
family tyrosine kinases that, in addition to phosphorylating 
MuSK, phosphorylate SIRPα1 to activate Shp2, which then 
dephosphorylates (on tyr527) and stimulates more src, and 
thus more SIRPα1/Shp2, etc., to propagate the dispersal sig-
nal that disassembles pre-patterned AChR clusters at extras-
ynaptic sites. Locally at postsynaptic sites, SIRPα1/Shp2 
signaling triggered by MuSK/src acts through a feedback loop 
to restrain the MuSK-initiated AChR clustering signal, which 
helps generate new AChR clusters selectively at postsynaptic 
sites. This form of regenerative signaling through src, SIRPα1 
and Shp2 also has built-in self-regulation because Shp2 can 
dephosphorylate SIRPα1 to control its own activation state.BMC Neuroscience 2008, 9:70 http://www.biomedcentral.com/1471-2202/9/70
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nel activity is blocked using bungarotoxin or curare and
no electrical activity or twitching is detected in muscle
[7,9,20]. Moreover, during NMJ formation in vivo in
zebrafish, pre-patterned AChR clusters are redistributed
when saturating concentrations of bungarotoxin are used
or even when the bungarotoxin is added together with
inhibitors of sodium channels to further ensure blockade
of all neuronal activity [22]. Thus, in these muscle cells,
ACh-dependent AChR channel opening appears to be
unnecessary for redistributing pre-patterned AChR aggre-
gates during NMJ formation. Whether ACh can subtly
influence the effectiveness with which other synaptogenic
stimuli disperse pre-patterned clusters, however, requires
further investigation.
In contrast to the above findings, in rodent and chick
myotubes AChR agonists reduce surface AChR clusters
[12,13] and muscle electrical activity suppresses extra-syn-
aptic AChR synthesis [60,61]. Other studies have revealed
a more direct role of ACh in AChR cluster disassembly, as
summarized by this recent model [19]: ACh elevates mus-
cle intracellular Ca2+ and stimulates the protease calpain,
which cleaves a protein named p35 to generate a p25 frag-
ment [19]; p25 potently activates the protein kinase Cdk5,
which disperses AChR clusters [17-19]. At the NMJ agrin
promotes calpain's interaction with rapsyn, which inhib-
its calpain and suppresses p25 production to locally limit
Cdk5 activity and block AChR dispersal [19]. Thus agrin is
thought to protect synaptic AChRs against dispersal by
ACh [16]. However, as discussed in these studies, some
aspects of this dispersal pathway warrant further investiga-
tion. For example, calpain is activated in muscle more rap-
idly than Cdk5, suggesting that additional unknown
factors regulate Cdk5 during dispersal [19]. Since Cdk5
phosphorylation sites have not been found in AChR sub-
units, it is also unclear exactly how Cdk5 disperses AChR
clusters [18]. Intriguingly, AChR activity, which favors dis-
persal in embryonic muscle, stabilizes AChRs during syn-
aptic competition [62], which could be due to changes in
the molecular makeup of AChR subunits or clusters dur-
ing development [18]. And, the elevation of intracellular
Ca2+ by agonists of AChRs and L-type calcium channels
actually promote AChR clustering [63,64], suggesting that
Ca2+ can either favor AChR cluster assembly and stabiliza-
tion or cluster destabilization and dispersal (through cal-
pain/Cdk5).
Roles of Shp2 or other tyrosine phosphatases in ACh-
dependent AChR dispersal have not been described, but
phosphatase inhibition blocks ACh-independent disper-
sal caused by defects in src signaling [29,65,66] or intrac-
ellular Ca2+ flux [67]. Shp2's function at the NMJ in vivo
also remains elusive, although one study [68] has
reported that NMJs appear normal around birth in mice in
which Shp2 expression is reduced in muscle. In that study
the presence of residual Shp2 in muscle was not ruled out
and the formation of pre-patterned AChR clusters ~E14
and the dispersal of these clusters by ~E17 were not exam-
ined [68]. Several other findings, however, argue in favor
of Shp2's involvement in NMJ development: Shp2 regu-
lates neuregulin/ErbB signaling and AChR gene expres-
sion [44], Shp2 limits agrin/MuSK-dependent formation
of new AChR clusters [25,43], and Shp2 promotes the dis-
assembly of pre-patterned (this study). Interestingly, Shp2
associates with MuSK and is able to stabilize AChR clus-
ters in rodent myotubes [65], which could be due to its
ability to activate src. However, excessive src kinase or
tyrosine phosphatase activity also destabilizes AChR clus-
ters in these cells [65], which is compatible with our find-
ings vis-à-vis SIRPα1 and Shp2 and the inhibition of
AChR clustering [25,43] and the facilitation of dispersal
(this study). Lastly, tyrosine phosphatases have recently
also been found to regulate the membrane insertion of
AChRs at the NMJ [69] suggesting that additional novel
functions of Shp2 and other phosphatase in NMJ develop-
ment await discovery.
Conclusion
During the earliest stages of NMJ establishment, motor
innervation of muscle induces the clustering of AChRs at
incipient synapses as well as the disassembly of pre-pat-
terned AChR aggregates formed in muscle before innerva-
tion. In amphibian muscle, synaptogenic stimuli direct
both of these processes independently of AChR activity,
with the former process being suppressed by tyrosine
phosphatases and the latter being mediated by phos-
phatases. In this study we found that pharmacological or
molecular manipulation of one specific phosphatase –
Shp2 – produced quantifiable changes in the dispersal of
pre-patterned AChR clusters in Xenopus muscle cells:
whereas dispersal was blocked by inhibitors of Shp2 sign-
aling, it was accelerated under conditions elevating mus-
cle Shp2 protein or activity levels. Our results suggest a
role of Shp2 (and its regulators such as SIRPα1) in not
only limiting AChR cluster formation [25,43] but also in
promoting the disassembly of pre-patterned AChR clus-
ters by synaptogenic stimuli. Functioning in these two dis-
tinct ways Shp2 may enhance the efficiency with which
AChRs are concentrated at developing NMJs and depleted
from non-synaptic regions of muscle. The participation of
other muscle tyrosine phosphatases in the dispersal of
pre-patterned AChR clusters, by synaptogenic stimuli or
by ACh, and the potential involvement of Shp2 signaling
in the dispersal of AChR clusters by ACh remain to be
tested.
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